Clinical Trial Update: Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adjuvant hypofractionated intensity-modulated radiation therapy with an incorporated boost for early-stage breast cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED